The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain

Pain

Volumn 83, Issue 2, 1999, Pages 339-345

  Gear, Robert W ^a   Miaskowski, Christine ^a   Gordon, Newton C ^a   Paul, Steven M ^a,b   Heller, Philip H ^c   Levine, Jon D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER FOUNDATION HOSPITAL   (United States)

Author keywords

Dose response; Men; Opioids; Placebo; Third molars; Women

Indexed keywords

BUTORPHANOL; DIAZEPAM; KAPPA OPIATE RECEPTOR AGONIST; MEPIVACAINE; MORPHINE; NALBUPHINE; NITROUS OXIDE; OPIATE; PENTAZOCINE; PLACEBO;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTAL SURGERY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOOTH EXTRACTION; TOOTH PAIN;

EID: 0032882252     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00119-0     Document Type: Article

References (28)

1. Arcaya J.L., Cano G., Gomez G., Maixner W., Suarex-Roca H. Dynorphin A increases substance P release from trigeminal primary afferent C-fibers. Eur J Pharmacol. 366:1999;27-34.
2. Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain. 64:1996;535-543.
3. Chavkin C., James I.F., Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science. 215:1982;413-415.
4. Dickenson A.H., Knox R.J. Antagonism of mu-opioid receptor-mediated inhibitions of nociceptive neurones by U50488H and dynorphin A1-13 in the rat dorsal horn. Neurosci Lett. 75:1987;229-234.
5. Errick J.K., Heel R.C. Nalbuphine: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs. 26:1983;191-211.
6. Faucett J., Gordon N., Levine J. Differences in postoperative pain severity among four ethnic groups. J Pain Symptom Manage. 9:1994;383-389.
7. Fillingim R.B., Maixner W. Gender differences in the responses to noxious stimuli. Pain Forum. 4:1995;209-221.
8. Gear R.W., Gordon N.C., Heller P.H., Paul S., Miaskowski C., Levine J.D. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett. 205:1996;207-209.
9. Gear R.W., Miaskowski C., Gordon N.C., Paul S., Heller P.H., Levine J.D. Significantly greater analgesia in females compared to males after kappa-opioids. Nature Med. 2:1996;1248-1250.
10. Gordon N.C., Gear R.W., Heller P.H., Paul S., Miaskowski C., Levine J.D. Enhancement of morphine analgesia by the GABAB agonist baclofen. Neuroscience. 69:1995;345-349.
11. Grevert P., Albert L.H., Goldstein A. Partial antagonism of placebo analgesia by naloxone. Pain. 16:1983;129-143.
12. Halpern S.H., Carter J.H. Narcotic agonists versus agonist-antagonist for relief of labor pain: a meta-analysis. Anesth Analg. 82:1996;S159.
13. Hersh E.V., Ochs H., Quinn P., MacAfee K., Cooper S.A., Barasch A. Narcotic receptor blockade and its effect on the analgesic response to placebo and ibuprofen after oral surgery. Oral Surg Oral Med Oral Pathol. 75:1993;539-546.
14. Hew E., Foster K., Gordon R., Hew-Sang E. A comparison of nalbuphine and meperidine in treatment of postoperative pain. Can J Anaesth. 34:1987;462-465.
15. Jaffee J.H., Martin W.R. Opioid analgesics and antagonists. Gilman A.G., Rall T.W., Nies A.S., Taylor P. Goodman and Gilman's The pharmacological basis of therapeutics. 1990;485-521 Pergamon Press, New York.
16. Jaillon P., Gardin M.E., Lecocq B., Richard M.O., Meignan S., Blondel Y., Grippat J.C., Bergnieres J., Vergnoux O. Pharmacokinetics of nalbuphine in infants, young healthy volunteers, and elderly patients. Clin Pharmacol Ther. 46:1989;226-233.
17. Levine J.D., Gordon N.C. Influence of the method of drug administration on analgesic response. Nature. 312:1984;755-756.
18. Levine J.D., Gordon N.C., Fields H.L. The mechanism of placebo analgesia. Lancet. 2:1978;654-657.
19. Loomis C.W., Penning J., Milne B. A study of the analgesic interaction between intrathecal morphine and subcutaneous nalbuphine in the rat. Anesthesiology. 71:1989;704-710.
20. Pan Z.Z., Tershner S.A., Fields H.L. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. Nature. 389:1997;382-385.
21. Pande A.C., Pyke R.E., Greiner M., Cooper S., Benjamin R., Pierce M.W. Analgesic efficacy of the κ-receptor agonist, enadoline, in dental surgery pain. Clin Neuropharmacol. 19:1996;92-97.
22. Ramarao P., Jablonski H.I. Jr, Rehder K.R., Bhargava H.N. Effect of kappa-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant rats. Eur J Pharmacol. 156:1988;239-246.
23. Schmauss C., Herz A. Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats. Eur J Pharmacol. 135:1987;429-431.
24. Suarez-Roca H., Maixner W. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J Pharmacol Exp Ther. 264:1993;648-653.
25. Tulunay F.C., Jen M.F., Chang J.K., Loh H.H., Lee N.M. Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia. J Pharmacol Exp Ther. 219:1981;296-298.
26. Unruh A.M. Gender variations in clinical pain experience. Pain. 65:1996;123-167.
27. Wilson S.J., Errick J.K., Balkon J. Pharmacokinetics of nalbuphine during parturition. Am J Obstet Gynecol. 155:1986;340-344.
28. Zola E.M., McLeod D.C. Comparative effects and analgesic efficacy of the agonist-antagonist opioids. Drug Intell Clin Pharm. 17:1983;411-417.